STORM Therapeutics - Harnessing the power or Epigenetics
STOR Tue, 17 Sep 2019, 09:00am BST
STORM Therapeutics is a University of Cambridge spin-out, translating the ground-breaking work of Professors Tony Kouzarides and Eric Miska in RNA epigenetics into the discovery of first-in-class drugs in oncology and other diseases. It is the leading company currently tackling disease through modulating RNA modifying enzymes and is developing a unique platform to address these enzyme classes, including RNA methyltransferases.
Industry: Health Care
Moneta Building, Cambridge, United Kingdom